BEIGHTON SCORE
BS
Description
Beighton Score test checks how flexible your joints are to see if conditions like joint hypermobility or Ehlers-Danlos Syndrome might be affecting you. During the test, your doctor will assess how much your joints, such as those in your fingers, elbows, knees, and spine, can move and assign a score between 0 and 9 based on their range of motion. A higher score indicates increased flexibility, which can sometimes lead to joint pain, instability, or frequent dislocations. This test is especially helpful for people dealing with persistent joint issues or a family history of connective tissue disorders. It’s also useful for identifying patterns that could explain symptoms like recurring injuries or chronic discomfort. The results help doctors diagnose the underlying cause of your symptoms and plan treatments, such as physical therapy or pain management. Monitoring your Beighton Score over time can provide insights into changes and support better joint health.
Procedure
Non-Invasive
Sample Type
No biological sample is needed for this test.
Test Category
Joint Function
Procedure Category
Assess
Units
Points
Test Groups
Physical Function Group: Tests within this group assess various aspects of physical function, offering insights into an individual's mobility, strength, and endurance. These tests help evaluate overall physical health and identify potential limitations or areas for improvement.
Optimal Range
For All Individuals:
Conventional Unit: 0–3 pts
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 0–3 pts
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Connective tissue disorders
Ehlers-Danlos syndromes (Group of genetic connective tissue disorders affecting skin, joints, and blood vessels)
Hypermobility spectrum disorders (Conditions characterized by excessive joint flexibility)
Joint laxity (Looseness or instability of joints)
Juvenile idiopathic arthritis (Chronic arthritis in childr...
Key Reasons For Testing
Assessment of Joint Hypermobility: Provides a standardized evaluation of joint flexibility and laxity.
Diagnosis of Joint Hypermobility Syndrome (JHS): Identifies JHS or hypermobility-related Ehlers-Danlos syndrome (EDS) based on joint flexibility and movement patterns.
Screening Tool for Connective Tissue Disorders: Assists in detecting signs of disorders like Ehlers-Danlos syndrome, Marfan syndrome, or osteogenesis imperfecta.
Risk Assessment for Musculoskeletal Injuries: Identifies risks for dislocations or ligament injuries associated with hypermobility.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis. 1973;32(5):413-418.
[2] Remvig L, Jensen DV, Ward RC. Epidemiology of generalized joint hypermobility and basis for the proposed criteria to be used in the diagnosis of benign joint hypermobility syndrome: Review of the literature. J Rheumatol.2007;34(4):804-809.
[3] Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003;57(3):163-166.
[4] Russek LN. Hypermobility syndrome. Phys Ther. 1999;79(6):591-599.
[5] Castori M, Camerota F, Celletti C, et al. Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: A pilot study on 21 patients. Am J Med Genet A. 2010;152A(3):556-564.
[6] Juul-Kristensen B, Rogind H, Jensen DV, Remvig L. Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. Rheumatology (Oxford). 2007;46(12):1835-1841.
[7] Scheper MC, Engelbert RH, Rameckers EA, et al. Children with generalized joint hypermobility and musculoskeletal complaints: state of the art on diagnostics, clinical characteristics, and treatment. Pediatr Rheumatol Online J.2013;11:33.
[8] Tinkle BT, Bird HA, Grahame R, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48-69.
[9] Pacey V, Tofts L, Adams RD, Munn J, Nicholson LL. Joint hypermobility syndrome: A review for clinicians. J Paediatr Child Health. 2015;51(4):373-380.
[10] Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8-26.
[11] Remvig L, Flycht L, Christensen KB, Juul-Kristensen B. Lack of consensus on tests and criteria for generalized joint hypermobility, benign joint hypermobility syndrome, and joint hypermobility syndrome. Am J Med Genet A.2014;164A(3):591-596.